Kenvue Inc. (NYSE:KVUE) Shares Sold by Tradition Wealth Management LLC

Tradition Wealth Management LLC lowered its position in shares of Kenvue Inc. (NYSE:KVUE) by 14.3% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 14,830 shares of the company’s stock after selling 2,471 shares during the quarter. Tradition Wealth Management LLC’s holdings in Kenvue were worth $343,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in KVUE. Janus Henderson Group PLC increased its position in shares of Kenvue by 53.7% during the first quarter. Janus Henderson Group PLC now owns 165,162 shares of the company’s stock worth $3,541,000 after purchasing an additional 57,679 shares in the last quarter. Atria Investments Inc lifted its holdings in Kenvue by 20.0% in the 1st quarter. Atria Investments Inc now owns 112,194 shares of the company’s stock valued at $2,408,000 after purchasing an additional 18,663 shares in the last quarter. Cetera Investment Advisers boosted its stake in Kenvue by 183.9% during the 1st quarter. Cetera Investment Advisers now owns 449,506 shares of the company’s stock worth $9,646,000 after purchasing an additional 291,179 shares during the last quarter. Cetera Advisors LLC grew its holdings in shares of Kenvue by 202.0% during the first quarter. Cetera Advisors LLC now owns 212,097 shares of the company’s stock worth $4,552,000 after buying an additional 141,858 shares in the last quarter. Finally, EverSource Wealth Advisors LLC raised its position in shares of Kenvue by 78.6% in the first quarter. EverSource Wealth Advisors LLC now owns 4,155 shares of the company’s stock valued at $89,000 after buying an additional 1,829 shares during the last quarter. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on the stock. Piper Sandler raised their price target on shares of Kenvue from $20.00 to $21.00 and gave the stock a “neutral” rating in a research note on Monday, September 23rd. Jefferies Financial Group began coverage on Kenvue in a research report on Tuesday, September 24th. They issued a “buy” rating and a $27.00 price target for the company. Deutsche Bank Aktiengesellschaft lifted their price objective on Kenvue from $23.00 to $24.00 and gave the stock a “buy” rating in a research report on Wednesday, August 7th. Royal Bank of Canada downgraded Kenvue from an “outperform” rating to a “sector perform” rating and set a $24.00 target price for the company. in a research note on Tuesday, September 24th. Finally, Bank of America boosted their price target on shares of Kenvue from $24.00 to $27.00 and gave the company a “buy” rating in a research report on Tuesday, October 22nd. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat.com, Kenvue presently has a consensus rating of “Hold” and an average target price of $22.64.

Kenvue Price Performance

Shares of KVUE opened at $24.08 on Monday. The firm has a 50-day simple moving average of $22.94 and a two-hundred day simple moving average of $20.99. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.00 and a quick ratio of 0.69. Kenvue Inc. has a 1-year low of $17.67 and a 1-year high of $24.46. The stock has a market cap of $46.17 billion, a PE ratio of 43.78, a P/E/G ratio of 2.19 and a beta of 1.36.

Kenvue (NYSE:KVUE) last announced its earnings results on Thursday, November 7th. The company reported $0.28 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.27 by $0.01. Kenvue had a return on equity of 21.43% and a net margin of 6.88%. The company had revenue of $3.90 billion for the quarter, compared to analyst estimates of $3.92 billion. During the same quarter in the previous year, the company earned $0.31 earnings per share. The firm’s quarterly revenue was down .4% compared to the same quarter last year. As a group, analysts forecast that Kenvue Inc. will post 1.07 EPS for the current year.

Kenvue Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, November 27th. Shareholders of record on Wednesday, November 13th were given a $0.205 dividend. This represents a $0.82 annualized dividend and a yield of 3.41%. The ex-dividend date of this dividend was Wednesday, November 13th. Kenvue’s dividend payout ratio is currently 149.09%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.